Health care stocks were declining late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 0.5%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, Upexi (UPXI) shares soared 152% after the company said it was investigating an instance of possible stock manipulation.
Avalon GloboCare (ALBT) shares jumped past 10% after saying Friday it signed a memorandum of understanding with Qi Diagnostics for the planned co-development of a cannabis breathalyzer.
HCA Healthcare (HCA) shares tumbled 9%. The company's Q3 results missed analyst estimates as Hurricane Helene impacted some of its facilities, while the hospital operator expects a further hurricane-related hit in the ongoing three-month period.
ImmunityBio (IBRX) shares surged 28% after the company reported late Thursday dosing of the first patients in a phase 1 trial that will assess its CAR-NK cellular therapy as a potential treatment for non-Hodgkin's lymphoma.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。